These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 6319876)

  • 1. Comparison of the action of putative endogenous kappa-agonists, leumorphin and rimorphin in vitro.
    Suda M; Nakao K; Yoshimasa T; Ikeda Y; Sakamoto M; Yanaihara C; Yanaihara N; Numa S; Imura H
    Life Sci; 1983; 33 Suppl 1():275-8. PubMed ID: 6319876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel opioid peptide, leumorphin, acts as an agonist at the kappa opiate receptor.
    Suda M; Nakao K; Yoshimasa T; Ikeda Y; Sakamoto M; Yanaihara N; Numa S; Imura H
    Life Sci; 1983 Jun; 32(24):2769-75. PubMed ID: 6134225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human leumorphin is a potent, kappa opioid receptor agonist.
    Suda M; Nakao K; Yoshimasa T; Sakamoto M; Morii N; Ikeda Y; Yanaihara C; Yanaihara N; Numa S; Imura H
    Neurosci Lett; 1984 Sep; 50(1-3):49-52. PubMed ID: 6149506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of dynorphin-selective Kappa receptors in mouse vas deferens and guinea pig ileum. Spare receptor fraction as a determinant of potency.
    Cox BM; Chavkin C
    Mol Pharmacol; 1983 Jan; 23(1):36-43. PubMed ID: 6135144
    [No Abstract]   [Full Text] [Related]  

  • 5. Evidence that dynorphin-(1-13) acts as an agonist on opioid kappa-receptors.
    Oka T; Negishi K; Suda M; Sawa A; Fujino M; Wakimasu M
    Eur J Pharmacol; 1982 Jan; 77(2-3):137-41. PubMed ID: 6277659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The choice of opiate receptor subtype by neo-endorphins.
    Oka T; Negishi K; Kajiwara M; Watanabe Y; Ishizuka Y; Matsumiya T
    Eur J Pharmacol; 1982 Apr; 79(3-4):301-5. PubMed ID: 6284522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of porcine leumorphin and some of its biological activities.
    Yamamoto Y; Yanaihara C; Katsumaru Y; Mochizuki T; Tobe A; Egawa M; Imura H; Numa S; Yanaihara N
    Regul Pept; 1983 May; 6(2):163-8. PubMed ID: 6308716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid receptor selectivity of dynorphin gene products.
    James IF; Fischli W; Goldstein A
    J Pharmacol Exp Ther; 1984 Jan; 228(1):88-93. PubMed ID: 6141278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid peptides derived from pre-proenkephalin B sequence: biological evaluation in guinea pig ileum and mouse vas deferens.
    Sánchez-Blázquez P; Garzón J; Lee NM
    Proc West Pharmacol Soc; 1983; 26():85-8. PubMed ID: 6688470
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro pharmacology of the opioid peptides, enkephalins and endorphins.
    Waterfield AA; Smokcum RW; Hughes J; Kosterlitz HW; Henderson G
    Eur J Pharmacol; 1977 May; 43(2):107-16. PubMed ID: 17538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The choice of opioid receptor subtype in isolated preparations by dynorphins.
    Oka T; Aoki K; Kajiwara M
    Life Sci; 1983; 33 Suppl 1():311-4. PubMed ID: 6141492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that endogenous 6-(ARG or LYS)-opioid peptides can interact with kappa-receptors as agonists.
    Oka T; Negishi K
    Life Sci; 1982 Oct 18-25; 31(16-17):1707-10. PubMed ID: 6130430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro study of the interaction of salmon calcitonin with mu, delta and kappa opioid agonists.
    Martín MI; Alfaro MJ; Goicoechea C; Colado MI
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Mar; 347(3):324-8. PubMed ID: 8386807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide E and other proenkephalin-derived peptides are potent kappa opiate receptor agonists.
    Quirion R; Weiss AS
    Peptides; 1983; 4(4):445-9. PubMed ID: 6316294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effects of somatostatin and enkephalins on the guinea pig ileum and the rat vas deferens.
    Jhamandas K; Elliott J
    Can J Physiol Pharmacol; 1980 Nov; 58(11):1389-92. PubMed ID: 6111385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative antagonism by naltrexone and naloxone of mu, kappa, and delta agonists.
    Takemori AE; Portoghese PS
    Eur J Pharmacol; 1984 Sep; 104(1-2):101-4. PubMed ID: 6094203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selectivities of opioid peptide analogues as agonists and antagonists at the delta-receptor.
    Corbett AD; Gillan MG; Kosterlitz HW; McKnight AT; Paterson SJ; Robson LE
    Br J Pharmacol; 1984 Sep; 83(1):271-9. PubMed ID: 6091824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid activity of pro-enkephalin-derived peptides in mouse vas deferens and guinea pig ileum.
    Sánchez-Blázquez P; Garzón J
    Neurosci Lett; 1985 Nov; 61(3):267-71. PubMed ID: 3001596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leumorphin is a novel endogenous opioid peptide in man.
    Suda M; Nakao K; Sakamoto M; Yoshimasa T; Morii N; Yanaihara N; Numa S; Imura H
    Biochem Biophys Res Commun; 1984 Aug; 123(1):148-55. PubMed ID: 6548137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioligands for probing opioid receptors.
    Paterson SJ; Corbett AD; Gillan MG; Kosterlitz HW; McKnight AT; Robson LE
    J Recept Res; 1984; 4(1-6):143-54. PubMed ID: 6098650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.